title: Ropinirole-induced Pisa syndrome in Parkinson disease.
abstract: Pisa syndrome (PS), also known as pleurothotonus, is an abnormal posture characterized by lateral flexion of the trunk that typically disappears in supine position. In Parkinson disease (PD), an abnormal forward flexion of the trunk (defined as camptocormia) is a common observation and has been interpreted as a sign of dystonia. Few reports have described PS mainly related to dopaminergic therapy in this kind of patients.Levodopa/carbidopa, levodopa/benserazide, levodopa/carbidopa/entacapone, pergolide, and pramipexole may cause PS, whereas no reports for ropinirole have been described.Here, we describe a case of a patient with PD who developed severe and reversible PS due to ropinirole intake.
authors.affiliation: Department of Neurology, Neurocenter of Southern Switzerland, Lugano, Switzerland.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Galati
authors.forename: Jens Carsten
authors.initials: JC
authors.lastname: Möller
authors.forename: Claudio
authors.initials: C
authors.lastname: Städler
mesh_terms: D000368:Aged; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D004421:Dystonia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D013577:Syndrome
chemical_list: D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole